Breaking News
8 hours ago
Vaibhavi M.
Agios says FDA has not yet issued a final decision on mitapivat sNDA for alpha and beta thalassemia as labeling and REMS review continues.
Vaibhavi M.
Roche reports 3-year STARGLO data showing Columvi plus GemOx doubled overall survival in relapsed or refractory DLBCL patients.
Vaibhavi M.
Praxis reports positive EMBOLD data for relutrigine, showing strong seizure reduction and favorable safety, and plans FDA meeting for potential NDA.
Vaibhavi M.
Roche receives EU approval for Gazyva/Gazyvaro with MMF in active lupus nephritis, offering a new treatment option to slow kidney damage.
Vaibhavi M.